Kliniska studier vid Tema Cancer

Biobank Esofagus/ventrikel biopsi. Studie av tumörgenetiska förändringar vid cancer i matstrupe eller magsäck.

Fredrik Klevebro

NEEDS. NEoadjuvant chemoradiotherapy for Esophageal squamous cell carcinoma versus Definitive chemoradiotherapy with salvage Surgery as needed 

Magnus Nilsson

CARDIA trial. Surgery for adenocarcinoma of the gastroesophageal junction (GREJ) type II: Transthoracic esophagectomy vs. Transhiatal extended gastrectomy

Magnus Nilsson

GOPRO. Patientrapporterad livskvalitet och erfarenhet av vården efter diagnos och vid behandling av cancer i matstrupe-och magsäck.

Berit Sunde

SARONG. Open label international multicentre randomised controlled trial of intensive surveillance vs. standard postoperative follow-up in patients undergoing surgical resection for oesophageal and gastric cancer

Maria Lampi

CASE-studien. Postoperativt delirium i samband med behandling av cancer i magsäck eller matstrupe

Maria Lampi

Endeavor pilotstudie. Endoskopisk borstcytologi och singelcell klonal dynamik av tidig Barrett-neoplasi för kostnadseffektiv surveillance och prediktion av återfall: prospektiv pilot inför en randomiserad kontrollerad studie

Fredrik Klevebro

JEDI. Radiologic contrast evaluation and symptoms of late delayed gastric conduit emptying after esophagectomy - the European multicenter JEDI study

Fredrik Klevebro

IPa Gastric . Randomised Phase III Trial of First Line Intraperitoneal Paclitaxel and Systemic Therapy versus Systemic Therapy Alone in Gastric Cancer Patients with Peritoneal Metastase

Lisa Liu Burström

Biobank eso/vent operation.

Fredrik Klevebro

CO-SNAR. COmpletion Sentinel Node resection with or without minimally invasive endoscopic cooperative surgery following non-cuRative Endoscopic Submucosal Dissection (CO-SNARE trial

Ioannis Rouvelas

FIMMUN. Immunceller och fibroblaster vid pancreassjukdom

Poya Ghorbani

IPMN-IMM. En studie av immunförsvarets celler i blod och mag-tarmsystemets organ hos vuxna patienter med gastrointestinala sjukdomar

Niklas Björkström

FeDUP. Fecal dysbiosis and undernutrition in pancreatic cancer patients (delstudie tilll PanTuMiMe)

Matthias Löhr

FAPI-46/FAPI-PET. PET imaging of tumors with strong desmoplastic reaction in pancreas, bile ducts and ventricle by a novel tracer, 68Ga-FAPI-46 = Fibroblast Activation Protein Inhibitor

Rimma Axelsson

CEL3A. Nivåer av fekalt elastas i individer med CELA3A-mutationer

Matthias Löhr

Anocca PDAC. A non-interventional study of patients with advanced Pancreatic Ductal Adenocarcinoma (PDAC) in conjunction with first-line Standard of Care to determine T-cell fitness for manufacturing of future autologous cell therapies

Maximilian Kordes

IMCODE003-GO4479. A PHASE II, OPEN-LABEL, MULTICENTER, RANDOMIZED STUDY OF THE EFFICACY AND SAFETY OF ADJUVANT AUTOGENE CEVUMERAN PLUS ATEZOLIZUMAB AND mFOLFIRINOX VERSUS mFOLFIRINOX ALONE IN PATIENTS WITH RESECTED PANCREATIC DUCTAL ADENOCARCINOMA

Maximilian Kordes

PRECODE. PRECODE= pANCreATIC Cancer OrganoiDS ReSEARCH nETWORK

Matthias Löhr

GUIDE.MRD. GUIDing multi-modal therapies against Minimal Residual Disease by liquid biopsies

Marco Gerling

PANCAID. Biomarkörer i blod för tidig upptäckt av bukspottkörtelcancer

Matthias Löhr

PEI-Heart. Sarcopenia and pancreatic exocrine insufficiency in patients with chronic heart failure and heart transplantation

Miroslav Vujasonovic

PEI-HH (hematomakros). Pancreatic exocrine insufficiency in patients with hemochromatosis

Miroslav Vujasinovic

HPB multiomik Pilot. Molekylär profilering av hepatopankreatobiliär cancer

Ernesto Sparrelid

Pan-MetS. Pancreas and metabolic syndrome

Miroslav Vujasinovic

BMS-CA2400030 – PMRT5. A Randomized, Phase 2/3 Study Comparing BMS-986504 in Combination with Nab-paclitaxel and Gemcitabine versus Placebo in Combination with Nab-paclitaxel and Gemcitabine in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletio

Marco Gerling

LIVIMM. Studier av immunförsvarets celler i blod och lever hos vuxna patienter med leversjukdom.

Niklas Björkström

DyNAmiC. Dynamic Profiling of Circulating Vesicle-borne Nucleic Acids in Human Liver Cancer

Stefan Gilg

New COMET. En randomiserad studie mellan ablation och resektion av levermetastaser från tjock- och ändtarmscancer

Jennie Engstrand

ScanPan 1. A population-based assessment of curative intended multimodal treatment in patients with oligometastatic pancreatic cancer responsive to neoadjuvant chemotherapy

Ernesto Sparrelid

ROBOCOP. Robotic-assisted contra open resection for suspected or confirmed gallbladder cancer (ROBOCOP) An international, multi-centre, open-label, randomized controlled superiority trial

Christian Sturesson

DRAGON 2. DRAGON 2 – An international multicenter randomized controlled trial to compare combined Portal and Hepatic Vein Embolization (PVE/HVE) with PVE alone

Ernesto Sparrelid

PSC-Prognos/Skandpsc. Diagnostiska och prognostiska markörer vid skleroserande cholangit

Annika Bergquist

BIGMAP-studien. Biokemiska, kliniska och genetiska markörer för uppföljning och prognostisering vid levercirros

Per Stål

Kommunikation och information vid PCS-diagnos (primär sklerosera. Patientupplevelse av kommunikation och information från sjukvården vid diagnos primär skleroserande kolangit

Tina Gustavell

helics. Hemostasis in liver cirrohosis and hepatocellur carcinoma

Per Stål

ASCTRACE. En explorativ pilotstudie med syfte att kartlägga T- och B-cellers funktion i ascites och blod hos patienter med dekompenserad levercirros med och utan spontan bakteriell peritonit (SBP)

Per Stål

INSPEL. Instructed home-based Physical Exercise for patients with Liver cirrhosis

Hannes Hagström

TAK-999-3001. A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency–Associated Liver Disease With METAVIR Stage F2 to F4 Fibrosis

Staffan Wahlin

TAK-999-3002. A Randomized, Double -blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency–Associated Liver Disease With METAVIR Stage F1 Fibrosis

Staffan Wahlin

KALIB. Biomarkörer vid leversjukdom

Hannes Hagström

CHANNEL. Kartläggning av vita blodkroppars reaktion mot tumörceller hos patienter med levercellscancer – ett pilotprojekt

Per Stål

STARLIGHT-222291. A Dose-Finding, Double-Blind, Placebo-ControlledPhase 2 Study to Evaluate the Efficacy and Safety ofGSK4532990 for Steatohepatitis in Adults withAlcohol-related Liver Disease (ALD)

Hannes Hagström

DETECT-HCC. A comparative study of MRI and ultrasound for detection of primary hepatocellular carcinoma, body composition and risk factors for decompensation in liver cirrhosis

Magnus Holmér

pTTL-LIVER. Personalised cell therapy, pTTL, in colorectal cancer patients with liver metastases – a feasibility study

Stefan Gilg

EV-HCC. Analys av extracellulära vesiklar för riskbedömning av trombos vid levercancer

Per Stål

Pechora. A phase 1, open-label positron emission tomography trial to assess changes in liver uptake of[68Ga]Ga-FAPI-46 following oral administration of single doses of AZD2389 to patients withadvanced liver fibrosis (PECHORA)

Hannes Hagström

RILIEF-Rilzabrutinib-EFC1735. A randomized, Phase 3, double-blind, 52-week study to evaluate the efficacy and safety of rilzabrutinib compared to placebo in adult participants with active IgG4-related diseas

Miroslav Vujasinovic